Miguel Santín
Quick facts
Marketed products
- Rifampicin alone · Infectious Disease
Rifampicin inhibits bacterial RNA polymerase, preventing transcription and blocking bacterial protein synthesis. - Rifampicin plus Isoniazid
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: